Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung Cancer
Status:
Unknown status
Trial end date:
2020-10-01
Target enrollment:
Participant gender:
Summary
This is a randomized, multicenter, open, controlled phase III trial. 388 subjects with stage
IIIB who were not eligible for radical surgery or radiotherapy, stage IV or recurrent
squamous cell NSCLC were enrolled in this study .The subjects will be randomly assigned to
one of the two treatment groups at a 1: 1 ratio, and stratified by sex, ECOG physical status,
smoking status, disease staging.